X-GEN CAR T PLATFORM Trademark

Trademark Overview

On Thursday, February 18, 2021, a trademark application was filed for X-GEN CAR T PLATFORM with the United States Patent and Trademark Office. The USPTO has given the X-GEN CAR T PLATFORM trademark a serial number of 90533614. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2024. This trademark is owned by Tmunity Therapeutics, Inc.. The X-GEN CAR T PLATFORM trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for use in medical and clinical cell therapy; pharmaceutical preparations for the treatment of cancer; therapeutic reagents for the treatment of cancer; gene therapy products, namely, genetically engineered cells for immunotherapy purposes
x-gen car t platform

General Information

Serial Number90533614
Word MarkX-GEN CAR T PLATFORM
Filing DateThursday, February 18, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements

Goods and ServicesBiological preparations for use in medical and clinical cell therapy; pharmaceutical preparations for the treatment of cancer; therapeutic reagents for the treatment of cancer; gene therapy products, namely, genetically engineered cells for immunotherapy purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTmunity Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameTmunity Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Trademark Events

Event DateEvent Description
Monday, February 22, 2021NEW APPLICATION ENTERED
Wednesday, May 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 14, 2021ASSIGNED TO EXAMINER
Monday, September 20, 2021NON-FINAL ACTION WRITTEN
Monday, September 20, 2021NON-FINAL ACTION E-MAILED
Monday, September 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 4, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, November 4, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 4, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, November 4, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, November 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 6, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, July 6, 2022SOU EXTENSION 1 FILED
Wednesday, July 6, 2022SOU EXTENSION 1 GRANTED
Friday, July 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 17, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 17, 2023SOU EXTENSION 2 FILED
Tuesday, January 17, 2023SOU EXTENSION 2 GRANTED
Thursday, January 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 17, 2023SOU EXTENSION 3 FILED
Monday, July 17, 2023SOU EXTENSION 3 GRANTED
Wednesday, July 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 9, 2024SOU EXTENSION 4 FILED
Tuesday, January 9, 2024SOU EXTENSION 4 GRANTED
Thursday, January 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

platform cancer treatment therapy preparations genetically namely purposes engineered cells products